ramelteon has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwashita, M; Izawa, T; Kobayashi, Y; Osanai, K; Otsu, M; Sakai, K | 1 |
| Carazo, A; Casado, J; de la Cueva, P; León, J; Maté, A; Muñoz de Rueda, P; Quiles, R; Ruíz, S; Ruíz-Extremera, A; Salmerón, J; Sanjuán, L | 1 |
2 other study(ies) available for ramelteon and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells.
Topics: Cell Line, Tumor; Cell Proliferation; Depression, Chemical; Endometrial Neoplasms; Female; Gene Expression; Humans; Indenes; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2 | 2017 |
Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer.
Topics: Aged; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Immunoblotting; Indenes; Male; Melatonin; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sex Factors | 2012 |